These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 156767)

  • 1. Serum eosinophil chemotactic factor levels in patients with bullous pemphigoid, drug reactions and atopic eczema.
    Czarnetzki BM; Kalveram KJ; Dierksmeier U
    J Invest Dermatol; 1979 Aug; 73(2):163-5. PubMed ID: 156767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophil chemotactic factor (ECF) in blister fluid of dermatological diseases.
    Dierksmeier U; Frosch PJ; Czarnetzki BM
    Br J Dermatol; 1980 Jan; 102(1):43-8. PubMed ID: 6990957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bullous pemphigoid: a cause of peripheral blood eosinophilia.
    Bushkell LL; Jordon RE
    J Am Acad Dermatol; 1983 May; 8(5):648-51. PubMed ID: 6345605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An eosinophil chemotactic factor present in blister fluids of bullous pemphigoid patients.
    Baba T; Sonozaki H; Seki K; Uchiyama M; Ikesawa Y; Toriisu M
    J Immunol; 1976 Jan; 116(1):112-6. PubMed ID: 1107422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of a low molecular weight eosinophil polymorphonuclear leukocyte chemotactic factor by anaplastic squamous cell carcinomas of human lung.
    Goetzl EJ; Tashjian AH; Rubin RH; Austen KF
    J Clin Invest; 1978 Mar; 61(3):770-80. PubMed ID: 641154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum eosinophil cationic protein (ECP) in bullous pemphigoid.
    Caproni M; Palleschi GM; Falcos D; D'Agata A; Cappelli G; Fabbri P
    Int J Dermatol; 1995 Mar; 34(3):177-80. PubMed ID: 7751092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of eosinophils in the pathogenic mechanisms of blister formation in bullous pemphigoid].
    Ichiki M
    Nihon Hifuka Gakkai Zasshi; 1983 Aug; 93(9):943-52. PubMed ID: 6363765
    [No Abstract]   [Full Text] [Related]  

  • 8. Eosinophil chemotactic factor (ECF). III. Generation in human peripheral leukocytes.
    König W; Czarnetzki BM; Lichtenstein LM
    Int Arch Allergy Appl Immunol; 1978; 56(4):364-75. PubMed ID: 344230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of human eosinophil polymorphonuclear leukocyte migration and function.
    Goetzl EJ
    Am J Pathol; 1976 Nov; 85(2):419-36. PubMed ID: 793410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of neutrophil-derived eosinophil chemotactic factor (ECF) in human and guinea pig skin.
    Czarnetzki BM; Frosch PJ; Vakilzadeh F; Panneck WB
    J Invest Dermatol; 1980 Feb; 74(2):109-11. PubMed ID: 7351498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotactic heterogeneity of eosinophils in Kimura's disease.
    Saita N; Ueno M; Yoshida M; Kimura T; Ando M; Hirashima M
    Int Arch Allergy Immunol; 1994; 104 Suppl 1(1):21-3. PubMed ID: 8155998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphologic and functional evidence for release of mast-cell products in bullous pemphigoid.
    Wintroub BU; Mihm MC; Goetzl EJ; Soter NA; Austen KF
    N Engl J Med; 1978 Feb; 298(8):417-21. PubMed ID: 340950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The regulation of tissue eosinophil chemotactic factor and inhibitor in allergic skin lesions of Freund's complete adjuvant-treated guinea-pigs.
    Hirashima M; Tashiro K; Hayashi H
    Immunology; 1984 Mar; 51(3):441-50. PubMed ID: 6365742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophil chemotactic factor (ECF). I. Release from polymorphonuclear leukocytes by the calcium ionophore A23187.
    Czarnetzki BM; König W; Lichtenstein LM
    J Immunol; 1976 Jul; 117(1):229-34. PubMed ID: 778263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Type IV allergic reaction (delayed type)].
    Hirashima M
    Nihon Rinsho; 1993 Mar; 51(3):669-74. PubMed ID: 8492441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bullous pemphigoid blister fluid stimulates eosinophil colony formation and activates eosinophils.
    Varigos GA; Morstyn G; Vadas MA
    Clin Exp Immunol; 1982 Dec; 50(3):555-62. PubMed ID: 6762270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eosinophils are a Major Source of Interleukin-31 in Bullous Pemphigoid.
    Rüdrich U; Gehring M; Papakonstantinou E; Illerhaus A; Engmann J; Kapp A; Hartmann K; Meyer NH; Gibbs BF; Raap U
    Acta Derm Venereol; 2018 Aug; 98(8):766-771. PubMed ID: 29693698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent severe staphylococcal infections, eczematoid rash, extreme elevations of IgE, eosinophilia, and divergent chemotactic responses in two generations.
    Blum R; Geller G; Fish LA
    J Pediatr; 1977 Apr; 90(4):607-9. PubMed ID: 839376
    [No Abstract]   [Full Text] [Related]  

  • 19. Inactivation of polymorphonuclear-neutrophil derived eosinophil chemotactic factor by human serum.
    König W; Czarnetzki BM
    Int Arch Allergy Appl Immunol; 1978; 57(5):399-410. PubMed ID: 352966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte activation in bullous diseases: release of granular proteins in bullous pemphigoid and pemphigus vulgaris.
    Czech W; Schaller J; Schöpf E; Kapp A
    J Am Acad Dermatol; 1993 Aug; 29(2 Pt 1):210-5. PubMed ID: 8393016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.